Elekta revises order backlog down by 4.9 billion Swedish krona, targets 14% EBIT margin
Elekta announced a significant adjustment to its order backlog, cancelling orders valued at 4.9 billion Swedish Krona following a proactive review aimed at improving profitability and predictability.
The revised backlog now stands at 36.9 billion Swedish Krona, after also factoring in 1.7 billion Swedish Krona in positive net sales and new orders, and a negative foreign exchange impact of 4.3 billion Swedish Krona, the company stated.
During its Investor Update, Elekta reiterated its mid-term financial targets, including restoring gross margins to pre-pandemic levels and achieving an earnings before interest and taxes (EBIT) margin of at least 14%.
The company also highlighted strong market reception for its new Evo linear accelerator in Europe and the Asia-Pacific region.
More from this issuer
Related coverage
Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.
Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.
Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.
Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.